Index Fund Advisors Inc. Invests $621,000 in Zoetis Inc. $ZTS

Key Points

• Index Fund Advisors Inc. has invested $621,000 in Zoetis Inc. by acquiring 3,980 shares during the second quarter.
• Zoetis recently reported earnings of $1.76 per share, exceeding analysts' expectations, with quarterly revenue of $2.46 billion, up 4.2% year-over-year.
• The company declared a quarterly dividend of $0.50, representing an annualized yield of 1.4%, with the ex-dividend date set for October 31st.

Index Fund Advisors Inc. bought a new stake in shares of Zoetis Inc. (NYSE:ZTS - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 3,980 shares of the company's stock, valued at approximately $621,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of ZTS. Nova Wealth Management Inc. acquired a new position in shares of Zoetis in the 1st quarter worth approximately $25,000. 1248 Management LLC bought a new stake in Zoetis during the first quarter worth approximately $27,000. Saudi Central Bank acquired a new position in Zoetis in the first quarter worth approximately $29,000. Cornerstone Planning Group LLC increased its holdings in shares of Zoetis by 79.3% in the first quarter. Cornerstone Planning Group LLC now owns 199 shares of the company's stock valued at $30,000 after buying an additional 88 shares in the last quarter. Finally, REAP Financial Group LLC lifted its position in shares of Zoetis by 201.5% during the 2nd quarter. REAP Financial Group LLC now owns 196 shares of the company's stock valued at $31,000 after acquiring an additional 131 shares during the last quarter. 92.80% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the company. Piper Sandler raised their price objective on Zoetis from $210.00 to $215.00 and gave the stock an "overweight" rating in a research note on Monday, August 11th. Leerink Partners lowered Zoetis from an "outperform" rating to a "market perform" rating and decreased their price target for the company from $180.00 to $155.00 in a research report on Thursday, July 17th. Stifel Nicolaus downgraded Zoetis from a "buy" rating to a "hold" rating and cut their price objective for the stock from $165.00 to $160.00 in a report on Wednesday, June 18th. Argus reaffirmed a "buy" rating and set a $190.00 price objective on shares of Zoetis in a research note on Tuesday, September 9th. Finally, Leerink Partnrs downgraded shares of Zoetis from a "strong-buy" rating to a "hold" rating in a research report on Thursday, July 17th. Four research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company's stock. According to data from MarketBeat, Zoetis presently has an average rating of "Hold" and a consensus price target of $196.71.

Zoetis Trading Down 1.6%

Shares of NYSE ZTS opened at $141.05 on Monday. The company has a current ratio of 1.76, a quick ratio of 1.04 and a debt-to-equity ratio of 1.05. Zoetis Inc. has a one year low of $139.34 and a one year high of $196.55. The business has a 50-day moving average price of $149.24 and a two-hundred day moving average price of $154.33. The firm has a market capitalization of $62.51 billion, a PE ratio of 24.28, a PEG ratio of 2.26 and a beta of 0.90.

Zoetis (NYSE:ZTS - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $1.76 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.62 by $0.14. The business had revenue of $2.46 billion during the quarter, compared to analyst estimates of $2.41 billion. Zoetis had a net margin of 27.83% and a return on equity of 56.90%. The firm's revenue was up 4.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.56 earnings per share. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, analysts predict that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 2nd. Stockholders of record on Friday, October 31st will be paid a $0.50 dividend. The ex-dividend date of this dividend is Friday, October 31st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.4%. Zoetis's dividend payout ratio is 34.42%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.